Clinical Trials Directory

Trials / Completed

CompletedNCT02618993

Effects of the Bilateral Mandibular Nerve Block (V3) in Mandibular Osteotomy

Effects of the Bilateral Mandibular Nerve Block (V3) in Mandibular Osteotomy: a Prospective, Randomized, Double-blind Versus Placebo Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
108 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The sensory innervation of the face depends on the trigeminal (fifth cranial) which is divided into three branches, the mandibular nerve (V3) having motor fibers to the temporal and masseter muscle. The regional anesthesia of the face has grown in recent years for performing certain actions under light general anesthesia or sedation. The mandibular block is a simple and reliable technique but little used. Yet it reduces postoperative pain sagittal osteotomy of the mandibular branch by reducing consumption of opioids and in the oropharynx cancer surgery. Made with ropivacaine, known for its vasoconstrictive action, it also improves the visibility of the operative field during mandibular osteotomies reducing bleeding. Despite a real clinical benefit (ease of implementation, latency and duration of action of the local anesthetic), the V3 block ropivacaine is not evaluated in the maxillofacial surgery.

Conditions

Interventions

TypeNameDescription
PROCEDURERealization of the V3 block in maxillofacial surgeriesbilateral mandibular block in maxillofacial surgeries

Timeline

Start date
2015-12-01
Primary completion
2018-06-30
Completion
2018-12-30
First posted
2015-12-02
Last updated
2022-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02618993. Inclusion in this directory is not an endorsement.